Condition (MeSH)
Adenoma, Bile Duct
ClinicalTrials.gov lists 4 trials for Adenoma, Bile Duct or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
4 of the 4 trials are tagged with Adenoma, Bile Duct itself; the rest are tagged with a narrower condition beneath it.
When did Adenoma, Bile Duct trials start? (4)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Not applicable
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2020 | 1 |
| 2019 | 1 |
| 2013 | 1 |
| 2012 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 4 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Adenoma, Bile Duct trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Not applicable | 2 |
| Observational | 1 |
How many Adenoma, Bile Duct trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 2 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Adenoma, Bile Duct? (5)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| The MicroRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes. | The Journal of biological chemistry | 2007 | Yes |
| Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 1992 | Yes |
| Optimal timing for stent replacement in malignant biliary tract obstruction. | Gastrointestinal endoscopy | 1993 | No |
| Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost? | Annals of surgery | 1985 | No |
| Colonic absorption of secondary bile-acids in patients with adenomatous polyps and in matched controls. | Lancet (London, England) | 1982 | No |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.